David MacDonald

4.8k citations

105 papers · 2.8k indexed · 1 hit paper · h-index 27

Impact in

Pathology and Forensic Medicine top 1%
- Lymphoma Diagnosis and Treatment
Genetics top 1%
- Chronic Lymphocytic Leukemia Research

Papers in ⓘ

Pathology and Forensic Medicine 47
- Lymphoma Diagnosis and Treatment 45
Surgery 37
- Orthopaedic implants and arthroplasty 19
- Total Knee Arthroplasty Outcomes 12
- Orthopedic Infections and Treatments 9

Co-authors: R. M. Smith (7 shared papers)A. Furlong (4 shared papers)P.V. Giannoudis (3 shared papers)P. de Boer (2 shared papers)S. J. Matthews (4 shared papers)Peter V. Giannoudis (9 shared papers)Richard van der Jagt (8 shared papers)Kathryn S. Kolibaba (10 shared papers)
Journals: Blood (18 papers)Journal of Clinical Oncology (9 papers)Injury (6 papers)Annals of Oncology (2 papers)European Journal of Vascular and Endovascular Surgery (2 papers)
Partner nations: Canada United States United Kingdom

In The Last Decade

David MacDonald

104 papers receiving 2.8k citations

Hit Papers

align trajectories log scale

Randomized trial of bendamustine-rituximab or R-CHOP/R-CVP in first-line treatment of indolent NHL or MCL: the BRIGHT study 2014 · 419 citations

Peers

Countries citing papers authored by David MacDonald

Since Specialization

Citations

This map shows the geographic impact of David MacDonald's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David MacDonald with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David MacDonald more than expected).

Fields of papers citing papers by David MacDonald

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David MacDonald. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David MacDonald. The network helps show where David MacDonald may publish in the future.

Co-authors

The 25 scholars most cited alongside David MacDonald, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with David MacDonald Line = papers co-authored together David MacDonald links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 105 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Randomized trial of bendamustine-rituximab or R-CHOP/R-CVP in first-line treatment of indolent NHL or MCL: the BRIGHT study Blood ·Ian W. Flinn, Richard van der Jagt, Brad S. Kahl, Peter Wood, Tim E. Hawkins, David MacDonald, Mark Hertzberg, Yiu‐Lam Kwan, David Simpson, Michael Craig, Kathryn S. Kolibaba, Samar Issa, Regina Clementi, Doreen M. Hallman, Mihaela Munteanu, Ling Chen, John M. Burke Hit paper breakdown →	2014	419
2	Nonunion of the femoral diaphysis Journal of Bone and Joint Surgery - British Volume ·P.V. Giannoudis, David MacDonald, S. J. Matthews, R. M. Smith, A. Furlong, P. de Boer	2000	291
3	First-Line Treatment of Patients With Indolent Non-Hodgkin Lymphoma or Mantle-Cell Lymphoma With Bendamustine Plus Rituximab Versus R-CHOP or R-CVP: Results of the BRIGHT 5-Year Follow-Up Study Journal of Clinical Oncology ·Ian W. Flinn, Richard van der Jagt, Brad S. Kahl, Peter Wood, Tim E. Hawkins, David MacDonald, David Simpson, Kathryn S. Kolibaba, Samar Issa, Julie Chang, Judith Trotman, Doreen M. Hallman, Ling Chen, John M. Burke	2019	166
4	Mechanism of lactide polymerization in the presence of stannous octoate: The effect of hydroxy and carboxylic acid substances Journal of Polymer Science Part A Polymer Chemistry ·Xichen Zhang, David MacDonald, Mattheus F. A. Goosen, Kimberley B. McAuley	1994	160
5	Nonunion of the femoral diaphysis Journal of Bone and Joint Surgery - British Volume ·P.V. Giannoudis, David MacDonald, Sarah J. Matthews, R. M. Smith, A. Furlong, P. de Boer	2000	154
6	Pharmacokinetics and safety of subcutaneous rituximab in follicular lymphoma (SABRINA): stage 1 analysis of a randomised phase 3 study The Lancet Oncology ·Andrew Davies, Francesco Merli, Biljana Mihaljević, Noppadol Siritanaratkul, P. Solal-Céligny, Martin Barrett, Claude Berge, Beate Bittner, Axel Boehnke, Christine McIntyre, David MacDonald	2014	90
7	Efficacy and safety of subcutaneous rituximab versus intravenous rituximab for first-line treatment of follicular lymphoma (SABRINA): a randomised, open-label, phase 3 trial The Lancet Haematology ·Andrew Davies, Francesco Merli, Biljana Mihaljević, Santiago Mercadal, Noppadol Siritanaratkul, Philippe Solal‐Céligny, Axel Boehnke, Claude Berge, Magali Genevray, Artem Zharkov, Mark Dixon, Michael Brewster, Martin Barrett, David MacDonald	2017	83
8	Posterior-Stabilized and Cruciate-Retaining Total Knee Replacement Clinical Orthopaedics and Related Research ·Charles R. Clark, Cecil H. Rorabeck, Steven J. MacDonald, David MacDonald, Judy Swafford, Dianna Cleland	2001	82
9	Long-term quality of life in trauma patients following the full spectrum of tibial injury (fasciotomy, closed fracture, grade IIIB/IIIC open fracture and amputation) Injury ·Peter V. Giannoudis, Paul Harwood, George Kontakis, M Allami, David MacDonald, Simon Kay, Paul Kind	2008	76
10	Exchange nailing for femoral shaft aseptic non-union Injury ·A. Furlong, Peter V. Giannoudis, Piet DeBoer, S. J. Matthews, David MacDonald, R. M. Smith	1999	74
11	Ibrutinib Plus Rituximab Versus Placebo Plus Rituximab for Waldenström's Macroglobulinemia: Final Analysis From the Randomized Phase III iNNOVATE Study Journal of Clinical Oncology ·Christian Buske, Alessandra Tedeschi, Judith Trotman, Ramón García‐Sánz, David MacDonald, Véronique Leblond, Beatrice Mahé, Charles Herbaux, Jeffrey Matous, Constantine S. Tam, Leonard T. Heffner, Marzia Varettoni, M. Lia Palomba, Chaim Shustik, Efstathios Kastritis, Steven P. Treon, Jerry Ping, Bernhard Hauns, Israel Arango‐Hisijara, (unknown)	2021	64
12	Reamed against unreamed nailing of the femoral diaphysis: a retrospective study of healing time Injury ·Peter V. Giannoudis, A. Furlong, David MacDonald, R. M. Smith	1997	55
13	Human walking, 2nd edn Current Orthopaedics ·David MacDonald	1996	54
14	Variation in the TNF Gene Promoter and Risk of Osteolysis After Total Hip Arthroplasty Journal of Bone and Mineral Research ·J. Mark Wilkinson, Anthony G. Wilson, I Stockley, Ian Scott, David MacDonald, A. J. Hamer, Gordon W. Duff, Richard Eastell	2003	51
15	Styrene migration from general-purpose and high-impact polystyrene into food-simulating solvents Food and Chemical Toxicology ·P.G. Murphy, David MacDonald, T.D. Lickly	1992	46
16	Segmental tibial fractures: an assessment of procedures in 27 cases Injury ·Peter V. Giannoudis, A. Hinsche, Andrew J. Cohen, David MacDonald, S. J. Matthews, R. M. Smith	2003	44
17	A Review of 202 Periprosthetic Fractures - Stem Revision and Allograft Improves Outcome for Type B Fractures Hip International ·G. Pavlou, Pavlos Panteliadis, David MacDonald, John Timperley, Graham A. Gie, Gordon Bancroft, Eleftherios Tsiridis	2011	42
18	Comparative reliability and diagnostic performance of conventional 3T magnetic resonance imaging and 1.5T magnetic resonance arthrography for the evaluation of internal derangement of the hip European Radiology ·A. Chopra, Andrew J. Grainger, B. Dube, R. M. L. Evans, Richard Hodgson, J. Conroy, David MacDonald, Philip Robinson	2017	38
19	A phase I/II study of sorafenib in combination with low dose cytarabine in elderly patients with acute myeloid leukemia or high-risk myelodysplastic syndrome from the National Cancer Institute of Canada Clinical Trials Group: trial IND.186 Leukemia & lymphoma ·David MacDonald, Sarit Assouline, Joseph Brandwein, Suzanne Kamel‐Reid, Elizabeth A. Eisenhauer, Stephen Couban, Stephen Caplan, Alison H. Foo, Wendy Walsh, Brian Leber	2012	37
20	Stimulation of the local femoral inflammatory response to fracture and intramedullary reaming Journal of Bone and Joint Surgery - British Volume ·John Morley, R. M. Smith, Hans‐Christoph Pape, David MacDonald, L. K. Trejdosiewitz, Peter V. Giannoudis	2008	37

About David MacDonald

David MacDonald is a scholar working on Pathology and Forensic Medicine, Surgery, Oncology, Genetics and Neurology, having authored 105 papers that have together received 2.8k indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (45 papers), Chronic Lymphocytic Leukemia Research (23 papers), Orthopaedic implants and arthroplasty (19 papers), CNS Lymphoma Diagnosis and Treatment (13 papers), Total Knee Arthroplasty Outcomes (12 papers), Viral-associated cancers and disorders (11 papers), Musculoskeletal synovial abnormalities and treatments (9 papers) and Orthopedic Infections and Treatments (9 papers). The work is most often cited by research in Pathology and Forensic Medicine (1.1k citations), Genetics (622 citations), Oncology (904 citations), Process Chemistry and Technology (93 citations) and Surgery (977 citations). David MacDonald has collaborated with scholars based in Canada, United States and United Kingdom. Frequent co-authors include R. M. Smith, A. Furlong, P.V. Giannoudis, P. de Boer, S. J. Matthews, Peter V. Giannoudis, Richard van der Jagt, Kathryn S. Kolibaba, Samar Issa and Ian W. Flinn. Their work appears in journals such as Blood, Journal of Clinical Oncology, Injury, Annals of Oncology and European Journal of Vascular and Endovascular Surgery.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact